Oxurion Pauses Its Investment Program in Crypto Assets

Temporary Suspension of the Investment Program

Oxurion has decided to temporarily suspend the execution of its financing program dedicated to investments in digital and crypto assets, according to the statement released on January 19. The company has reassessed this project, which was announced to the market on December 1, 2025, and aimed to consider an alternative asset class comparable to other financial investments. The company justifies this decision by the high volatility observed in the crypto asset markets as well as the current economic and geopolitical context. The company believes that it is not appropriate, at this stage, to continue the implementation of this project and has decided to defer any investment decision until better visibility on the market environment is obtained.

Conditions for Fund Disbursement Not Met

According to the statement, the suspensive conditions for the disbursement of the first tranche of financing have not been lifted. As a result, no funds have been drawn or received by the company to date, Oxurion specifies. The group emphasizes that this decision represents an adjustment of the schedule and strategic intentions and does not entail any change to its economic model or main activities. The pharmaceutical subcontracting company, based in Louvain, Belgium, indicates that it continues its growth strategy and acquisitions without change.

Specialization and Future Plans

Oxurion, listed on Euronext Brussels, specializes in taking majority stakes in European pharmaceutical subcontractors, according to the statement. The group aims to build an integrated entity of subcontractors serving the health sector players. The company indicates that it will inform the market of any further developments regarding this investment project in crypto assets. The company's headquarters are located in Louvain, Belgium.